title: [New innovative glucose-controlled pump enabling glucose control in a pregnant patient with diabetes].
abstract: Continuous glucose monitoring enables innovative insulin pumps to stop infusion of insulin at selected blood glucose thresholds. We present the first and successful Danish clinical case using this device, a Medtronics Veo insulin pump, in a patient with numerous cases of severe hypoglycaemia during earlier pregnancies. During this treatment insulin infusion was frequently stopped and severe hypoglycaemia prevented in the remaining part of pregnancy.
authors.affiliation: Klintemarken 15, 2860 Søborg. saschampl@gmail.com.
authors.forename: Sascha
authors.initials: S
authors.lastname: Pilemann-Lyberg
authors.forename: Anette Bratt
authors.initials: AB
authors.lastname: Solis
authors.forename: Elisabeth R
authors.initials: ER
authors.lastname: Mathiesen
authors.forename: Peter
authors.initials: P
authors.lastname: Gæde
mesh_terms: D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015918:Infusion Pumps, Implantable; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D007332:Insulin Infusion Systems; D011247:Pregnancy
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin